0001213900-23-081857.txt : 20231031 0001213900-23-081857.hdr.sgml : 20231031 20231031170829 ACCESSION NUMBER: 0001213900-23-081857 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231029 FILED AS OF DATE: 20231031 DATE AS OF CHANGE: 20231031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oron Assaf CENTRAL INDEX KEY: 0001792310 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38762 FILM NUMBER: 231365590 MAIL ADDRESS: STREET 1: C/O BIOMX LTD. STREET 2: 7 PINHAS SAPIR ST., FLOOR 2 CITY: NESS ZIONA STATE: L3 ZIP: 7414002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BiomX Inc. CENTRAL INDEX KEY: 0001739174 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 EINSTEIN ST., 4TH FLOOR CITY: NESS ZIONA STATE: L3 ZIP: 7414003 BUSINESS PHONE: (972) 72 394 2377 MAIL ADDRESS: STREET 1: 22 EINSTEIN ST., 4TH FLOOR CITY: NESS ZIONA STATE: L3 ZIP: 7414003 FORMER COMPANY: FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp. DATE OF NAME CHANGE: 20180430 4 1 ownership.xml X0508 4 2023-10-29 0 0001739174 BiomX Inc. PHGE 0001792310 Oron Assaf C/O BIOMX INC., 22 EINSTEIN ST., FLOOR 4 NESS ZIONA, L3 7414003 ISRAEL 0 1 0 0 Chief Business Officer 0 Common Stock Options - Right to Buy 1.691 2023-10-29 4 D 0 155363 0 D 2027-03-26 Common Stock 0 0 D Common Stock Options - Right to Buy 0.275 2023-10-29 4 A 0 155363 0 A 2027-03-26 Common Stock 0 0 D Common Stock Options - Right to Buy 1.973 2023-10-29 4 D 0 82667 0 D 2028-05-22 Common Stock 0 0 D Common Stock Options - Right to Buy 0.275 2023-10-29 4 A 0 82667 0 A 2028-05-22 Common Stock 0 0 D Common Stock Options - Right to Buy 2.031 2023-10-29 4 D 0 46966 0 D 2029-03-29 Common Stock 0 0 D Common Stock Options - Right to Buy 0.275 2023-10-29 4 A 0 46966 0 A 2029-03-29 Common Stock 0 0 D The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 03/26/2017 and provides for vesting over four years, with 25% of the shares subject to the option vested on 03/26/2018, and the remainder vested in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024. The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 05/22/2018 and provides for vesting over four years, with 25% of the shares subject to the option vested on 05/22/2019, and the remainder vested in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024. The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 03/29/2019 and provides for vesting over four years, with 25% of the shares subject to the option vested on 03/29/2020, and the remainder vested in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024. /s/ Assaf Oron 2023-10-31